Preventing depressive relapse is a major goal in the management of bipolar disorder. It has been shown that depression makes up around 72% of overall time spent ill in people with bipolar (Forte et al., 2015), and that bipolar depression specifically is associated with significant physical and mental morbidity, as well as increased mortality (Baldessarini et al., 2020).
Lithium is the first-line recommended medication for preventing bipolar depression (NICE, 2014). However, as a previous Elf blog has highlighted, prescription of lithium is declining, both in the UK and other...
Eating disorders (EDs) are mental health conditions characterised by disordered eating, and excessive focus on weight and body image. These disorders are often...
‘Borderline personality disorder’ (‘BPD’) is a controversial psychiatric diagnosis, argued to be misunderstood by many, plagued with problems of comorbidity and misdiagnosis, as...
Stigma towards individuals with mental health conditions such as depression is well documented (Wood et al., 2014) and highly common (see Pattie’s Mental...
Insomnia is a prevalent condition (affecting 10% of adults, 10-20% in primary care samples) whose key features are prolonged poor sleep, which affects...
Over 55 million people are living with dementia across the globe (WHO, 2023). Depending on the subtype of dementia, people experience different symptoms...
